Therapeutic drug monitoring of vancomycin: A retrospective cross-sectional study of blood draw timing and clinical outcomes.

While the observed differences in clinical outcomes, such as reduced cure rates, increased AKI, and higher in-hospital mortality, did not reach statistical significance, the trend toward worse outcomes with incorrect vancomycin TDM timing highlights the need for strict adherence to timing guidelines to support optimal patient care and antimicrobial stewardship.

also in 111,027 other papers